Free Trial

Forte Biosciences (FBRX) SEC Filings & 10K Form

Forte Biosciences logo
$13.55 +7.62 (+128.50%)
(As of 11/20/2024 ET)

Recent Forte Biosciences SEC Filings

DateFilerForm TypeView
11/20/2024
3:15 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:02 PM
ALGER ASSOCIATES INC (Filed by)
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Form SC 13G/A
10/02/2024
5:19 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:21 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:50 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
5:26 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
VINCENT RICHARD G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2024
5:28 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Kapoor Shivpreet Singh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2024
5:30 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
VINCENT RICHARD G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
5:31 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Kapoor Shivpreet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:05 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:06 PM
Brun Scott C. (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:07 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Williams Donald Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:08 PM
FINCK BARBARA K (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:09 PM
Doberstein Stephen K (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:10 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Kornfeld Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:11 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
GRYSKA DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:12 PM
Eichenfield Lawrence (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:37 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:02 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form ARS
07/19/2024
3:10 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form PRE 14A
07/03/2024
11:17 AM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
11:18 AM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:24 AM
Camac Fund, LP (Filed by)
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Form SC 13D/A
04/29/2024
4:22 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 10-K/A
04/02/2024
5:31 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:32 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:07 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:08 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:09 PM
FINCK BARBARA K (Reporting)
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:16 PM
Forte Biosciences, Inc. (Filer)
Forte Biosciences (Filer)
Form 8-K/A
02/14/2024
3:54 PM
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
TYBOURNE CAPITAL MANAGEMENT LTD (0001553936) (Filed by)
Form SC 13G
02/14/2024
3:56 PM
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
8:33 AM
Farallon Capital Partners, L.P. (Filed by)
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Form SC 13G/A
01/05/2024
4:27 PM
Camac Fund, LP (Filed by)
Forte Biosciences, Inc. (Subject)
Forte Biosciences (Subject)
Form SC 13D/A
12/20/2023
9:56 AM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
5:29 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:30 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
6:20 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:51 PM
Forte Biosciences, Inc. (Issuer)
Forte Biosciences (Issuer)
Wagner Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FBRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners